portal vein thrombosis
Information
- Disease name
- portal vein thrombosis
- Disease ID
- DOID:11695
- Description
- "A hepatic vascular disease that is characterized by a blood clot that forms within the hepatic portal vein." [url:http\://en.wikipedia.org/wiki/Portal_vein_thrombosis]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03009461 | Completed | Phase 2 | Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC With Major Portal Vein Tumor Thrombosis | June 1, 2017 | December 28, 2020 |
| NCT05360641 | Completed | Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal Vein Thrombosis Secondary to a Local Cause. | August 1, 2019 | March 31, 2022 | |
| NCT05541562 | Completed | A Practical Nomogram Based on Systemic Inflammatory Markers for Predicting Portal Vein Thrombosis in Patients With Liver Cirrhosis | January 1, 2013 | January 1, 2021 | |
| NCT03201367 | Completed | N/A | Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV | May 1, 2014 | August 1, 2016 |
| NCT03477149 | Completed | N/A | EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications | March 30, 2018 | March 11, 2020 |
| NCT05012501 | Completed | Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients | September 1, 2020 | February 28, 2021 | |
| NCT01095185 | Completed | Phase 3 | Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding | November 2010 | September 2013 |
| NCT02069457 | Completed | Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis | December 2013 | June 2015 | |
| NCT02250391 | Completed | Phase 3 | Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis | September 2014 | March 2016 |
| NCT01326949 | Completed | N/A | Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis | May 2011 | January 2016 |
| NCT04173429 | Completed | Phase 4 | Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis | January 1, 2017 | January 31, 2020 |
| NCT01470547 | Completed | Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry | April 2012 | December 2017 | |
| NCT02585713 | Completed | Phase 3 | Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism | November 20, 2015 | December 24, 2019 |
| NCT01556282 | Completed | N/A | TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis | March 2009 | January 2014 |
| NCT06005883 | Completed | Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk Scoring | April 10, 2021 | April 10, 2022 | |
| NCT04976543 | Completed | Phase 4 | Safety of Anticoagulant Therapy After Endoscopic Treatment | February 1, 2020 | June 28, 2022 |
| NCT05132192 | Completed | Living Donor Liver Transplantation to Patients With Portal Vein Thrombosis | January 1, 2013 | October 30, 2020 | |
| NCT05872841 | Not yet recruiting | Phase 2 | H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis | June 1, 2023 | June 30, 2025 |
| NCT06319131 | Not yet recruiting | N/A | Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT | May 1, 2024 | May 30, 2026 |
| NCT06150807 | Not yet recruiting | Portal Vein Thrombosis in Neonate With Umbilical Catheter | December 20, 2023 | January 30, 2025 | |
| NCT06122753 | Not yet recruiting | N/A | Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis | January 2024 | December 2026 |
| NCT06117488 | Not yet recruiting | Risk Factors and Management Outcome of Chronic Portal Vein Thrombosis in Children | November 1, 2023 | December 1, 2025 | |
| NCT03541057 | Recruiting | Vienna Vascular Liver Disease Study | December 12, 2017 | December 2024 | |
| NCT05625893 | Recruiting | Phase 2 | Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion | September 16, 2022 | December 31, 2025 |
| NCT05166239 | Recruiting | Phase 2 | HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT | January 10, 2022 | December 2024 |
| NCT05782556 | Recruiting | Freiburg TIPS Registry | January 1, 2023 | June 30, 2034 | |
| NCT02485184 | Recruiting | N/A | TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis | July 9, 2017 | December 31, 2024 |
| NCT04181931 | Recruiting | N/A | Neo-TACE-HAIC for PVTT-HCC | December 16, 2019 | December 30, 2024 |
| NCT04387695 | Recruiting | Phase 3 | SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT | April 30, 2020 | August 1, 2023 |
| NCT05123326 | Recruiting | Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome | October 15, 2021 | October 15, 2024 | |
| NCT00769873 | Terminated | Phase 2 | Anticoagulation Post Laparoscopic Splenectomy | October 2006 | May 2009 |
| NCT01690715 | Terminated | Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery | July 2012 | August 30, 2012 | |
| NCT04433481 | Unknown status | N/A | Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis | June 20, 2020 | May 31, 2022 |
| NCT02630095 | Unknown status | Phase 4 | The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCT | December 2015 | September 2018 |
| NCT02627053 | Unknown status | Phase 3 | Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study | December 2015 | December 2019 |
| NCT02398357 | Unknown status | Phase 4 | The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis | March 2015 | December 2017 |
| NCT03902678 | Unknown status | N/A | Role of EUS Guided FNA of Portal Vein Thrombus in the Diagnosis and Staging of Hepatocellular Carcinoma | May 11, 2017 | July 11, 2019 |
| NCT05339581 | Unknown status | N/A | IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation | May 20, 2022 | May 31, 2024 |
| NCT03631147 | Unknown status | N/A | The Effect of Rifaximin on Portal Vein Thrombosis | September 3, 2018 | December 31, 2019 |
| NCT03193502 | Unknown status | Phase 3 | Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis | May 1, 2014 | December 2020 |
| NCT03031717 | Unknown status | Clinical Course of Cirrhotic Patients With Portal Vein Thrombosis Treated With TIPS | January 1, 2017 | June 30, 2023 | |
| NCT02853526 | Unknown status | Phase 3 | TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV | July 2015 | December 2018 |
| NCT02733770 | Unknown status | N/A | Chances in Portal System Flow After Two Bariatric Procedures | January 1, 2017 | December 1, 2021 |
| NCT04055389 | Withdrawn | Phase 1 | Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis | January 1, 2021 | February 22, 2022 |
| NCT01631877 | Withdrawn | N/A | Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver | June 2012 | June 1, 2017 |
| NCT02526303 | Withdrawn | N/A | Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis |
- Disase is a (Disease Ontology)
- DOID:272
- Cross Reference ID (Disease Ontology)
- ICD10CM:I81
- Cross Reference ID (Disease Ontology)
- ICD9CM:452
- Cross Reference ID (Disease Ontology)
- NCI:C78565
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:155455003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0155773
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0030242
- MedGen concept unique identifier (MedGen Concept name)
- C0155773
- MedGen unique identifier (MedGen Concept name)
- 56372
- ICD10 preferred id (Insert disease from ICD10)
- D0007364
- ICD10 class code (Insert disease from ICD10)
- I81